Updating risk prediction tools: A case study in prostate cancer

Biometrical Journal

Volumn 54, Issue 1, 2012, Pages 127-142

  Ankerst, Donna P ^a,b,c   Koniarski, Tim ^d   Liang, Yuanyuan ^b,c   Leach, Robin J ^b   Feng, Ziding ^e   Sanda, Martin G ^f   Partin, Alan W ^g   Chan, Daniel W ^g   Kagan, Jacob ^h   Sokoll, Lori ^g   Wei, John T ⁱ   Thompson, Ian M ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b Mays Cancer Center at UT Health San Antonio   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d UNIVERSITY OF REGENSBURG   (Germany)

^e Fred Hutchinson Cancer Research Center   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g DEPARTMENT OF PATHOLOGY   (United States)

^h NATIONAL CANCER INSTITUTE   (United States)

ⁱ UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Calibration; Discrimination; Net benefit; Prostate cancer prevention trial; Risk prediction; Validation

Indexed keywords

DECISION MAKING; DIAGNOSIS; DISEASES; FORECASTING; RISK ASSESSMENT; UROLOGY;

CANCER PREVENTION; CASE-STUDIES; DISCRIMINATION; NET BENEFIT; PREDICTION TOOLS; PROSTATE CANCER PREVENTION TRIAL; PROSTATE CANCERS; RISK FACTORS; RISK PREDICTIONS; VALIDATION;

BIOMARKERS;

EID: 84855505772     PISSN: 03233847     EISSN: 15214036     Source Type: Journal    
DOI: 10.1002/bimj.201100062     Document Type: Article

References (33)

1. Ankerst, D. P., Groskopf, J., Day, J. R., Blase, A., Rittenhouse, H., Pollock, B. H., Tangen, C., Parekh, D., Leach, R. J. and Thompson, I. (2008). Predicting prostate cancer risk through incorporation of prostate cancer gene 3. Journal of Urology 180, 1303-1308.
2. Anscombe, F. J. (1967) Topics in the investigation of linear relations fitted by the method of least squares (with discussion). Journal of the Royal Statistical Society Series B 29, 1-52.
3. Chatfield, C. (1995). Model uncertainty, data mining, and statistical inference (with discussion). Journal of the Royal Statistical Society Series A 158, 419-466.
4. DeLong, E. R., DeLong, D. M. and Clarke-Pearson, D. L. (1988). Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44, 837-845.
5. Eyre, S. J., Ankerst, D. P., Wei, J. T., Nair, P. V., Regan, M. M., Bueti, G., Tang, J., Rubin, M. A., Kearney, M., Thompson, I. M. and Sanda, M. G. (2009). Validation in a multiple urology practice setting of the Prostate Cancer Prevention Trial calculator for predicting prostate cancer detection. Journal of Urology 182, 2653-2658.
6. Frühwirth-Schnatter, S. and Pyne, S. (2010). Bayesian interface for finite mixtures of univariate and multivariate skew-normal and skew-t distributions. Biostatistics 11, 317-336.
7. Gail, M. H., Brinton, L. A., Byar, D. P., Corle, D. K., Green, S. B., Schairer, C. and Mulvihill, J. J. (1989). Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. Journal of the National Cancer Institute 81, 1879-1886.
8. Gail, M. H., Costantino, J. P., Pee, D., Bondy, M., Newman, L., Selvan, M., Anderson, G. L., Malone, K. E., Marchbanks, P. A., McCaskill-Stevens, W., Norman, S. A., Simon, M. S., Spirtas, R., Usin, G. and Bernstein, L. (2007). Projecting individualized absolute invasive breast cancer risk in African American women. Journal of the National Cancer Institute 99, 1782-1792.
9. Greenland, S. (2008). The need for reorientation toward cost-effective prediction: comments on 'Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond' by M. J. et al., Statistics in Medicine. Statistics in Medicine 27, 199-206.
10. Grundy, S. M., Cleeman, J. I., Merz, C. N. B., Brewer, B. Jr., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C. and Stone, N. J. for the Coordinating Committee of the National Cholesterol Education Program (2004). Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation 110, 227-239.
11. Gu, W. and Pepe, M. S. (2009). Estimating the capacity for improvement in risk prediction with a marker. Biostatistics 10, 172-186.
12. Gu, W. and Pepe, M. S. (2011). Estimating the diagnostic likelihood ratio of a continuous marker. Biostatistics 12, 87-101.
13. Hernandez, D. J., Han, M., Humphreys, E. B., Mangold, L. A., Taneja, S. S., Childs, S. J., Bartsch, G. and Partin, A. W. (2009). Predicting the outcome of prostate biopsy: comparison of a novel logistic regression-based model, the prostate cancer risk calculator, and prostate-specific antigen level alone. British Journal Urology International 103, 609-614.
14. Izenman, A. J. (2008). Modern Multivariate Statistical Techniques. Springer, New York.
15. Janssen, K. J. M., Donders, A. R. T., Harrell, F. E. Jr., Vergouwe, Y., Chen, Q., Grobbee, D. E. and Moons, K. G. M. (2010). Missing covariate data in medical research: To impute is better than to ignore. Journal of Clinical Epidemiology 63, 721-727.
16. Janssens, A. C. J. W., Deng, Y., Borsboom, G. J. J. M., Eijkemans, M. J. C., Habbema, J. D. F. and Steyerberg, E. W. (2005). A new logistic regression approach for the evaluation of diagnostic test results. Medical Decision Making 25, 168-177.
17. Lemeshow, S. and Hosmer, D. W. Jr., (1982). A review of goodness of fit statistics for use in the development of logistic regression models. American Journal of Epidemiology 115, 92-106.
18. Liang, Y., Ankerst, D. P., Ketchum, N. S., Ercole, B., Shah, G., Shaughnessy, J. D. Jr., Leach, R. J. and Thompson, I. M. (2011). Prospective evaluation of operating characteristics of prostate cancer detection biomarkers. Journal of Urology 185, 104-110.
19. Nguyen, C. T., Yu, C., Moussa A., Kattan, M. W. and Jones, J. S. (2010). Performance of prostate cancer prevention trial risk calculator in a contemporary cohort screened for prostate cancer and diagnosed by extended prostate biopsy. Journal of Urology 183, 529-533.
20. Parekh, D. J., Ankerst, D. P., Higgins, B. A., Hernandez, J., Canby-Hagino, E., Brand, T., Troyer, D., Leach, R. and Thompson, I. M. (2006). External validation of the Prostate Cancer Prevention Trial risk calculator. Urology 68, 1152-1155.
21. Pencina, M. J., D'Agostino Sr., R. B., D'Agostino Jr., R. B., Vasan, R. S. (2008). Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Statistics in Medicine 27, 157-172.
22. Pepe, M. S., Etzioni, R., Feng, Z., Potter, J. D., Thompson, M. L., Thornquist, M., Winget, M. and Yasui, Y. (2001). Phases of biomarker development for early detection of cancer. Journal of the National Cancer Institute 93, 1054-1061.
23. Skates, S. J., Pauler, D. K. and Jacobs, I. J. (2001). Screening based on the risk of cancer calculation from Bayesian hierarchical change-point models of longitudinal markers. Journal of the American Statistical Association 96, 429-439.
24. Sokoll, L. J., Sanda, M. G., Feng, Z., Kagan, J., Mizrahi, I. A., Broyles, D. L., Partin, A. W., Srivasta, S., Thompson, I. M., Wei, J. T., Zhang, Z. and Chan, D. W. (2010). A prospective, multicenter National Cancer Institute Early Detection Research Network study of [-2]proPSA: improving prostate cancer detection and correlating with cancer aggressiveness. Cancer Epidemiology, Biomarkers and Prevention 19, 1193-1200.
25. Steyerberg, E. W. and Vickers, A. J. (2008). Decision curve analysis: a discussion. Medical Decision Making 28, 146-149.
26. Steyerberg, E. W., Vickers, A. J., Cook, N. R., Gerds, T., Gonen, M., Obuchowski, N., Pencina, M. J. and Kattan, M. W. (2010). Assessing the performance of prediction models, a framework for traditional and novel measures. Epidemiology 21, 128-138.
27. Steyerberg, E. W. (2010). Clinical Prediction Models. Springer, New York.
28. Thompson, I. M., Ankerst, D. P., Chi, C., Lucia, M. S., Goodman, P., Crowley, J. J., Parnes, H. L. and Coltman Jr., C. A. (2005). The operating characteristics of prostate-specific antigen in a population with initial PSA of 3. 0ng/mL or lower. Journal of the American Medical Association 294, 66-70.
29. Thompson, I. M., Ankerst, D. P., Chi, C., Goodman, P. J., Tangen, C. M., Lucia, M. S., Feng, Z., Parnes, H. L. and Coltman Jr., C. A. (2006). Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. Journal of the National Cancer Institute 98, 529-534.
30. van Buuren, S. (2007). Multiple imputation of discrete and continuous data by fully conditional specification. Statistical Methods in Medical Research 16, 219-242.
31. Vickers, A. J. and Elkin, E. B. (2006). Decision curve analysis: a novel method for evaluating prediction models. Medical Decision Making 26, 565-574.
32. Wolf, A. M. D., Wender, R. C., Etzioni, R., Thompson, I. M., D'Amico, A. V., Volk, R. J., Brooks, D. D., Dash, C., Guessous, I., Andrews, K., DeSantis, C. and Smith, R. A. (2010). American Cancer Society guideline for the early detection of prostate cancer: update 2010. CA Cancer Journal for Clinicians 60, 70-98.
33. Yates, J. F. (1982). External correspondence: decomposition of the mean probability score. Organizational Behavior and Human Performance 30, 132-156.